TY - JOUR AU - Fitzmaurice, C. AU - Dicker, D. PY - 2015 DA - 2015// TI - The global burden of cancer 2013 JO - JAMA VL - 1 ID - Fitzmaurice2015 ER - TY - JOUR AU - Heidenreich, A. AU - Bellmunt, J. AU - Bolla, M. PY - 2011 DA - 2011// TI - EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2010.10.039 DO - 10.1016/j.eururo.2010.10.039 ID - Heidenreich2011 ER - TY - JOUR AU - Mottet, N. AU - Bellmunt, J. AU - Bolla, M. PY - 2011 DA - 2011// TI - EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2011.01.025 DO - 10.1016/j.eururo.2011.01.025 ID - Mottet2011 ER - TY - JOUR AU - Shariat, S. F. AU - Karakiewicz, P. I. AU - Roehrborn, C. G. AU - Kattan, M. W. PY - 2008 DA - 2008// TI - An updated catalog of prostate cancer predictive tools JO - Cancer VL - 113 UR - https://doi.org/10.1002/cncr.23908 DO - 10.1002/cncr.23908 ID - Shariat2008 ER - TY - JOUR AU - Ross, P. L. AU - Gerigk, C. AU - Gonen, M. PY - 2002 DA - 2002// TI - Comparisons of nomograms and urologists’ predictions in prostate cancer JO - Semin Urol Oncol VL - 20 UR - https://doi.org/10.1053/suro.2002.32490 DO - 10.1053/suro.2002.32490 ID - Ross2002 ER - TY - JOUR AU - Walz, J. AU - Gallina, A. AU - Perrotte, P. PY - 2007 DA - 2007// TI - Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer JO - BJU Int VL - 100 UR - https://doi.org/10.1111/j.1464-410X.2007.07130.x DO - 10.1111/j.1464-410X.2007.07130.x ID - Walz2007 ER - TY - JOUR AU - Cohen, R. J. AU - O’Brien, B. A. PY - 2011 DA - 2011// TI - Comparative analysis of three risk assessment tools in Australian patients with prostate cancer JO - BJU Int VL - 108 UR - https://doi.org/10.1111/j.1464-410X.2011.10717.x DO - 10.1111/j.1464-410X.2011.10717.x ID - Cohen2011 ER - TY - JOUR AU - Evans, S. M. AU - Nag, N. AU - Roder, D. PY - 2016 DA - 2016// TI - Development of an international prostate cancer outcomes registry JO - BJU Int VL - 117 UR - https://doi.org/10.1111/bju.13258 DO - 10.1111/bju.13258 ID - Evans2016 ER - TY - STD TI - Medicine CfE-B. Critical appraisal of Prognostic studies. 2016 [cited 2016]; Available from: http://www.cebm.net/critical-appraisal/ UR - http://www.cebm.net/critical-appraisal/ ID - ref9 ER - TY - JOUR AU - Engineer, R. AU - Bhutani, R. AU - Mahantshetty, U. AU - Murthy, V. AU - Shrivastava, S. K. PY - 2010 DA - 2010// TI - From two-dimensional to three-dimensional conformal radiotherapy in prostate cancer: an Indian experience JO - Indian J Cancer VL - 47 UR - https://doi.org/10.4103/0019-509X.64718 DO - 10.4103/0019-509X.64718 ID - Engineer2010 ER - TY - JOUR AU - Zelefsky, M. J. AU - Chou, J. F. AU - Pei, X. PY - 2012 DA - 2012// TI - Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience JO - Brachytherapy VL - 11 UR - https://doi.org/10.1016/j.brachy.2011.08.003 DO - 10.1016/j.brachy.2011.08.003 ID - Zelefsky2012 ER - TY - JOUR AU - Marshall, R. A. AU - Buckstein, M. AU - Stone, N. N. AU - Stock, R. PY - 2014 DA - 2014// TI - Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center JO - Urol Oncol VL - 32 UR - https://doi.org/10.1016/j.urolonc.2013.03.004 DO - 10.1016/j.urolonc.2013.03.004 ID - Marshall2014 ER - TY - JOUR AU - Kaplan, A. AU - German, L. AU - Chen, J. AU - Matzkin, H. AU - Mabjeesh, N. J. PY - 2012 DA - 2012// TI - Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with 125iodine brachytherapy JO - BJU Int VL - 109 UR - https://doi.org/10.1111/j.1464-410X.2011.10748.x DO - 10.1111/j.1464-410X.2011.10748.x ID - Kaplan2012 ER - TY - JOUR AU - McKenna, D. A. AU - Coakley, F. V. AU - Westphalen, A. C. PY - 2008 DA - 2008// TI - Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience JO - Radiology VL - 247 UR - https://doi.org/10.1148/radiol.2471061982 DO - 10.1148/radiol.2471061982 ID - McKenna2008 ER - TY - JOUR AU - Rodrigues, G. AU - Lukka, H. AU - Warde, P. PY - 2013 DA - 2013// TI - The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis JO - Radiother Oncol VL - 109 UR - https://doi.org/10.1016/j.radonc.2013.07.020 DO - 10.1016/j.radonc.2013.07.020 ID - Rodrigues2013 ER - TY - JOUR AU - Yoshida, K. AU - Yamazaki, H. AU - Nakamura, S. PY - 2014 DA - 2014// TI - Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy JO - Anticancer Res VL - 34 ID - Yoshida2014 ER - TY - JOUR AU - Potters, L. AU - Roach, I. M. AU - Davis, B. J. PY - 2010 DA - 2010// TI - Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable JO - Int J Radiat Oncol Biol Phys VL - 76 UR - https://doi.org/10.1016/j.ijrobp.2009.03.031 DO - 10.1016/j.ijrobp.2009.03.031 ID - Potters2010 ER - TY - JOUR AU - Williams, S. G. AU - Buyyounouski, M. K. AU - Pickles, T. PY - 2008 DA - 2008// TI - Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 Men: statistical significance without predictive performance JO - Int J Radiat Oncol Biol Phys VL - 70 UR - https://doi.org/10.1016/j.ijrobp.2007.08.021 DO - 10.1016/j.ijrobp.2007.08.021 ID - Williams2008 ER - TY - BOOK AU - Vainshtein, J. M. AU - Schipper, M. AU - Vance, S. AU - Feng, F. Y. AU - Olson, K. B. AU - Hamstra, D. A. PY - 2014 DA - 2014// TI - Limitations of the cancer of the prostate risk assessment (CAPRA) prognostic tool for prediction of metastases and prostate cancer-specific mortality in patients treated with external beam radiation therapy PB - American Journal of Clinical Oncology CY - Cancer Clinical Trials ID - Vainshtein2014 ER - TY - JOUR AU - Delouya, G. AU - Krishnan, V. AU - Bahary, J. P. AU - Larrivee, S. AU - Taussky, D. PY - 2014 DA - 2014// TI - Analysis of the cancer of the prostate risk assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapy JO - Urology VL - 84 UR - https://doi.org/10.1016/j.urology.2014.05.032 DO - 10.1016/j.urology.2014.05.032 ID - Delouya2014 ER - TY - JOUR AU - Krishnan, V. AU - Delouya, G. AU - Bahary, J. P. AU - Larrivee, S. AU - Taussky, D. PY - 2014 DA - 2014// TI - The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapy JO - BJU Int VL - 114 UR - https://doi.org/10.1111/bju.12587 DO - 10.1111/bju.12587 ID - Krishnan2014 ER - TY - JOUR AU - Sanpaolo, P. AU - Barbieri, V. AU - Genovesi, D. PY - 2014 DA - 2014// TI - Biologically effective dose and definitive radiation treatment for localized prostate cancer. Treatment gaps do affect the risk of biochemical failure JO - Strahlenther Onkol VL - 190 UR - https://doi.org/10.1007/s00066-014-0642-0 DO - 10.1007/s00066-014-0642-0 ID - Sanpaolo2014 ER - TY - STD TI - Vainshtein JM, Schipper M, Vance S, Feng FY, Olson KB, Hamstra DA. Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy. Am J Clin Oncol. 2014 ID - ref23 ER - TY - JOUR AU - Cooperberg, M. R. AU - Pasta, D. J. AU - Elkin, E. P. PY - 2005 DA - 2005// TI - The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy JO - J Urol VL - 173 UR - https://doi.org/10.1097/01.ju.0000158155.33890.e7 DO - 10.1097/01.ju.0000158155.33890.e7 ID - Cooperberg2005 ER - TY - BOOK PY - 2000 DA - 2000// TI - Applied logistic regression PB - Wiley CY - New York ID - ref25 ER - TY - JOUR AU - Frank, S. J. AU - Levy, L. B. AU - Kuban, D. A. PY - 2009 DA - 2009// TI - Prostogram predicted brachytherapy outcomes are Not universally accurate: an analysis based on the M. D. Anderson cancer center experience with 125Iodine brachytherapy JO - J Urol VL - 181 UR - https://doi.org/10.1016/j.juro.2008.11.101 DO - 10.1016/j.juro.2008.11.101 ID - Frank2009 ER - TY - JOUR AU - Kattan, M. W. AU - Potters, L. AU - Blasko, J. C. PY - 2001 DA - 2001// TI - Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer JO - Urology VL - 58 UR - https://doi.org/10.1016/S0090-4295(01)01233-X DO - 10.1016/S0090-4295(01)01233-X ID - Kattan2001 ER - TY - JOUR AU - Bittner, N. AU - Merrick, G. S. AU - Galbreath, R. W. AU - Butler, W. M. AU - Adamovich, E. AU - Wallner, K. E. PY - 2010 DA - 2010// TI - Greater biopsy core number is associated with improved biochemical control in patients treated with permanent prostate brachytherapy JO - Int J Radiat Oncol Biol Phys VL - 78 UR - https://doi.org/10.1016/j.ijrobp.2010.02.068 DO - 10.1016/j.ijrobp.2010.02.068 ID - Bittner2010 ER - TY - JOUR AU - Feng, F. Y. AU - Qian, Y. AU - Stenmark, M. H. PY - 2011 DA - 2011// TI - Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2011.04.048 DO - 10.1016/j.ijrobp.2011.04.048 ID - Feng2011 ER - TY - BOOK AU - Hall, W. A. AU - Lawton, C. A. AU - Jani, A. B. AU - Pollack, A. AU - Feng, F. Y. PY - 2017 DA - 2017// TI - Biomarkers of outcome in patients with localized prostate cancer treated with radiotherapy PB - Elsevier CY - Seminars in radiation oncology ID - Hall2017 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement JO - Ann Intern Med VL - 162 UR - https://doi.org/10.7326/M14-0697 DO - 10.7326/M14-0697 ID - Collins2015 ER - TY - JOUR AU - Moons, K. G. AU - Altman, D. G. AU - Reitsma, J. B. PY - 2015 DA - 2015// TI - Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration JO - Ann Intern Med VL - 162 UR - https://doi.org/10.7326/M14-0698 DO - 10.7326/M14-0698 ID - Moons2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2014.639 DO - 10.1038/bjc.2014.639 ID - Collins2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement JO - BMC Med VL - 13 UR - https://doi.org/10.1186/s12916-014-0241-z DO - 10.1186/s12916-014-0241-z ID - Collins2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.g7594 DO - 10.1136/bmj.g7594 ID - Collins2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - members of Tg. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.11.025 DO - 10.1016/j.eururo.2014.11.025 ID - Collins2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement JO - Br J Surg VL - 102 UR - https://doi.org/10.1002/bjs.9736 DO - 10.1002/bjs.9736 ID - Collins2015 ER - TY - JOUR AU - Collins, G. S. AU - Reitsma, J. B. AU - Altman, D. G. AU - Moons, K. G. PY - 2015 DA - 2015// TI - Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) JO - Ann Intern Med VL - 162 UR - https://doi.org/10.7326/L15-5093-2 DO - 10.7326/L15-5093-2 ID - Collins2015 ER - TY - JOUR AU - Moons, K. G. AU - Altman, D. G. AU - Reitsma, J. B. AU - Collins, G. S. PY - 2015 DA - 2015// TI - New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD statement JO - Adv Anat Pathol VL - 22 UR - https://doi.org/10.1097/PAP.0000000000000072 DO - 10.1097/PAP.0000000000000072 ID - Moons2015 ER - TY - JOUR AU - Cooperberg, M. R. AU - Vickers, A. J. AU - Broering, J. M. AU - Carroll, P. R. PY - 2010 DA - 2010// TI - Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25456 DO - 10.1002/cncr.25456 ID - Cooperberg2010 ER - TY - JOUR AU - D'Ambrosio, D. J. AU - Li, T. AU - Horwitz, E. M. AU - Chen, D. Y. AU - Pollack, A. AU - Buyyounouski, M. K. PY - 2008 DA - 2008// TI - Does treatment duration affect outcome after radiotherapy for prostate cancer? JO - Int J Radiat Oncol Biol Phys VL - 72 UR - https://doi.org/10.1016/j.ijrobp.2008.03.011 DO - 10.1016/j.ijrobp.2008.03.011 ID - D'Ambrosio2008 ER - TY - JOUR AU - D'Amico, A. V. AU - Moran, B. J. AU - Braccioforte, M. H. AU - Dosoretz, D. AU - Salenius, S. AU - Katin, M. PY - 2009 DA - 2009// TI - Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.3992 DO - 10.1200/JCO.2008.20.3992 ID - D'Amico2009 ER - TY - JOUR AU - D'Amico, A. V. AU - Chen, M. H. AU - Catalona, W. J. AU - Sun, L. AU - Roehl, K. A. AU - Moul, J. W. PY - 2007 DA - 2007// TI - Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors JO - Cancer VL - 110 UR - https://doi.org/10.1002/cncr.22737 DO - 10.1002/cncr.22737 ID - D'Amico2007 ER - TY - JOUR AU - Denham, J. W. AU - Steigler, A. AU - Wilcox, C. AU - Lamb, D. S. AU - Joseph, D. AU - Atkinson, C. PY - 2008 DA - 2008// TI - Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70236-5 DO - 10.1016/S1470-2045(08)70236-5 ID - Denham2008 ER - TY - JOUR AU - Frank, S. J. AU - Levy, L. B. AU - Vulpen, M. AU - Crook, J. AU - Sylvester, J. AU - Grimm, P. PY - 2012 DA - 2012// TI - Outcomes after prostate brachytherapy are even better than predicted JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26307 DO - 10.1002/cncr.26307 ID - Frank2012 ER - TY - JOUR AU - Halverson, S. AU - Schipper, M. AU - Blas, K. AU - Lee, V. AU - Sabolch, A. AU - Olson, K. PY - 2011 DA - 2011// TI - The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse JO - Radiother Oncol VL - 101 UR - https://doi.org/10.1016/j.radonc.2011.05.080 DO - 10.1016/j.radonc.2011.05.080 ID - Halverson2011 ER - TY - JOUR AU - Huang, J. AU - Vicini, F. A. AU - Williams, S. G. AU - Ye, H. AU - McGrath, S. AU - Ghilezan, M. PY - 2012 DA - 2012// TI - Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? JO - Int J Radiat Oncol Biol Phys VL - 83 UR - https://doi.org/10.1016/j.ijrobp.2011.09.043 DO - 10.1016/j.ijrobp.2011.09.043 ID - Huang2012 ER - TY - JOUR AU - Kubicek, G. J. AU - Naguib, M. AU - Redfield, S. AU - Grayback, N. AU - Olszanski, A. AU - Dawson, G. PY - 2010 DA - 2010// TI - PSA decrease during combined-modality radiotherapy predicts for treatment outcome JO - Int J Radiat Oncol Biol Phys VL - 78 UR - https://doi.org/10.1016/j.ijrobp.2009.08.064 DO - 10.1016/j.ijrobp.2009.08.064 ID - Kubicek2010 ER - TY - JOUR AU - McKenna, D. A. AU - Coakley, F. V. AU - Westphalen, A. C. AU - Zhao, S. AU - Lu, Y. AU - Webb, E. M. PY - 2008 DA - 2008// TI - Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience JO - Radiology VL - 247 UR - https://doi.org/10.1148/radiol.2471061982 DO - 10.1148/radiol.2471061982 ID - McKenna2008 ER - TY - STD TI - Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, Hamstra DA. The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer. Radiation oncology (London, England). 2012;7:127. Pubmed Central PMCID: 3484035. ID - ref50 ER - TY - STD TI - Proust-Lima C, Taylor JM. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach. Biostatistics (Oxford, England). 2009;10(3):535-49. Pubmed Central PMCID: PMC2697347. Epub 2009/04/17. eng. ID - ref51 ER - TY - JOUR AU - Qian, Y. AU - Feng, F. Y. AU - Halverson, S. AU - Blas, K. AU - Sandler, H. M. AU - Hamstra, D. A. PY - 2011 DA - 2011// TI - The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2011.01.007 DO - 10.1016/j.ijrobp.2011.01.007 ID - Qian2011 ER - TY - JOUR AU - Sabolch, A. AU - Feng, F. Y. AU - Daignault-Newton, S. AU - Halverson, S. AU - Blas, K. AU - Phelps, L. PY - 2011 DA - 2011// TI - Gleason Pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2011.01.063 DO - 10.1016/j.ijrobp.2011.01.063 ID - Sabolch2011 ER - TY - JOUR AU - Slater, J. M. AU - Bush, D. A. AU - Grove, R. AU - Slater, J. D. PY - 2014 DA - 2014// TI - The prognostic value of percentage of positive biopsy cores, percentage of cancer volume, and maximum involvement of biopsy cores in prostate cancer patients receiving proton and photon beam therapy JO - Technol Cancer Res Treat VL - 13 ID - Slater2014 ER - TY - JOUR AU - Spratt, D. E. AU - Pei, X. AU - Yamada, J. AU - Kollmeier, M. A. AU - Cox, B. AU - Zelefsky, M. J. PY - 2013 DA - 2013// TI - Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 85 UR - https://doi.org/10.1016/j.ijrobp.2012.05.023 DO - 10.1016/j.ijrobp.2012.05.023 ID - Spratt2013 ER - TY - STD TI - Steigler A, Denham JW, Lamb DS, Spry NA, Joseph D, Matthews J, et al. Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: Data from the TROG 96.01 trial. Prostate cancer. 2012. ID - ref56 ER - TY - JOUR AU - Sylvester, J. E. AU - Grimm, P. D. AU - Wong, J. AU - Galbreath, R. W. AU - Merrick, G. AU - Blasko, J. C. PY - 2011 DA - 2011// TI - Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2010.05.042 DO - 10.1016/j.ijrobp.2010.05.042 ID - Sylvester2011 ER - TY - JOUR AU - Taylor, J. M. AU - Park, Y. AU - Ankerst, D. P. AU - Proust-Lima, C. AU - Williams, S. AU - Kestin, L. PY - 2013 DA - 2013// TI - Real-time individual predictions of prostate cancer recurrence using joint models JO - Biometrics VL - 69 UR - https://doi.org/10.1111/j.1541-0420.2012.01823.x DO - 10.1111/j.1541-0420.2012.01823.x ID - Taylor2013 ER - TY - JOUR AU - Thames, H. D. AU - Kuban, D. AU - Levy, L. B. AU - Horwitz, E. M. AU - Kupelian, P. AU - Martinez, A. PY - 2010 DA - 2010// TI - The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995 JO - Radiother Oncol VL - 96 UR - https://doi.org/10.1016/j.radonc.2010.03.020 DO - 10.1016/j.radonc.2010.03.020 ID - Thames2010 ER - TY - JOUR AU - Vance, S. M. AU - Stenmark, M. H. AU - Blas, K. AU - Halverson, S. AU - Hamstra, D. A. AU - Feng, F. Y. PY - 2012 DA - 2012// TI - Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with doseescalated external beam radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 83 UR - https://doi.org/10.1016/j.ijrobp.2011.09.005 DO - 10.1016/j.ijrobp.2011.09.005 ID - Vance2012 ER - TY - JOUR AU - Wattson, D. A. AU - Chen, M. H. AU - Moul, J. W. AU - Moran, B. J. AU - Dosoretz, D. E. AU - Robertson, C. N. PY - 2012 DA - 2012// TI - The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2011.11.023 DO - 10.1016/j.ijrobp.2011.11.023 ID - Wattson2012 ER - TY - JOUR AU - Westphalen, A. C. AU - Koff, W. J. AU - Coakley, F. V. AU - Muglia, V. F. AU - Neuhaus, J. M. AU - Marcus, R. T. PY - 2011 DA - 2011// TI - Prostate cancer: Prediction of biochemical failure after external-beam radiation therapy - Kattan nomogram and endorectal MR imaging estimation of tumor volume JO - Radiology VL - 261 UR - https://doi.org/10.1148/radiol.11110457 DO - 10.1148/radiol.11110457 ID - Westphalen2011 ER - TY - JOUR AU - Yu, M. AU - Taylor, J. M. G. AU - Sandler, H. M. PY - 2008 DA - 2008// TI - Individual Prediction in Prostate Cancer Studies using a Joint Longitudinal Survival-Cure Model JO - J Am Stat Assoc VL - 103 UR - https://doi.org/10.1198/016214507000000400 DO - 10.1198/016214507000000400 ID - Yu2008 ER - TY - JOUR AU - Yu, H. -. H. M. AU - Song, D. Y. AU - Tsai, Y. -. Y. AU - Thompson, T. AU - Frassica, D. A. AU - DeWeese, T. L. PY - 2007 DA - 2007// TI - Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy JO - Urology VL - 70 UR - https://doi.org/10.1016/j.urology.2007.03.020 DO - 10.1016/j.urology.2007.03.020 ID - Yu2007 ER - TY - JOUR AU - Zaorsky, N. G. AU - Li, T. AU - Devarajan, K. AU - Horwitz, E. M. AU - Buyyounouski, M. K. PY - 2012 DA - 2012// TI - Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network riskstratification method JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.27597 DO - 10.1002/cncr.27597 ID - Zaorsky2012 ER - TY - JOUR AU - Zelefsky, M. J. AU - Pei, X. AU - Chou, J. F. AU - Schechter, M. AU - Kollmeier, M. AU - Cox, B. PY - 2011 DA - 2011// TI - Dose escalation for prostate cancer radiotherapy: Predictors of long-term biochemical tumor control and distant metastases-free survival outcomes JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.08.029 DO - 10.1016/j.eururo.2011.08.029 ID - Zelefsky2011 ER - TY - JOUR AU - Zelefsky, M. J. AU - Shi, W. AU - Yamada, Y. AU - Kollmeier, M. A. AU - Cox, B. AU - Park, J. PY - 2009 DA - 2009// TI - Postradiotherapy 2-year prostatespecific antigen nadir as a predictor of long-term prostate cancer mortality JO - Int J Radiat Oncol Biol Phys VL - 75 UR - https://doi.org/10.1016/j.ijrobp.2008.12.067 DO - 10.1016/j.ijrobp.2008.12.067 ID - Zelefsky2009 ER - TY - JOUR AU - Zelefsky, M. J. AU - Kattan, M. W. AU - Fearn, P. AU - Fearon, B. L. AU - Stasi, J. P. AU - Shippy, A. M. PY - 2007 DA - 2007// TI - Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensitymodulated radiotherapy for prostate cancer JO - Urology VL - 70 UR - https://doi.org/10.1016/j.urology.2007.03.060 DO - 10.1016/j.urology.2007.03.060 ID - Zelefsky2007 ER - TY - JOUR AU - Zumsteg, Z. S. AU - Spratt, D. E. AU - Pei, I. AU - Zhang, Z. AU - Yamada, Y. AU - Kollmeier, M. PY - 2013 DA - 2013// TI - A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy JO - Eur Urol VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.03.033 DO - 10.1016/j.eururo.2013.03.033 ID - Zumsteg2013 ER -